Research Archives - Page 3 of 3 - Whitman-Walker

Category: Research

Research, Whitman-Walker Impact

December 1, 2019

Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations.

Research, Whitman-Walker Impact

September 23, 2019

Antiretroviral Treatment Interruptions Among Black and Latina Transgender Women Living with HIV: Characterizing Co‑occurring, Multilevel Factors Using the Gender Affirmation Framework

Research, Whitman-Walker Impact

September 23, 2019

Transgender and Nontrans Patients Do Not Receive Statistically Different Quality Primary Care at Whitman-Walker Health, 2008–2016

Research, Whitman-Walker Impact

September 8, 2019

American Cohort to Study HIV Acquisition Among Transgender Women in High-Risk Areas (The LITE Study): Protocol for a Multisite Prospective Cohort Study in the Eastern and Southern United States

Research, Whitman-Walker Impact

July 18, 2019

Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals

Research, Whitman-Walker Impact

June 8, 2019

Integration of HIV preexposure prophylaxis (PrEP) services with family planning services: an evaluation using the RE-AIM framework